Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Investment Income (2023 - 2024)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Non Operating Investment Income of -$42898.0 for Q3 2024, down 546.58% year-over-year from $9606.0 in Q4 2023, and down 53.4% quarter-over-quarter from -$27964.0 in Q2 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$42898.0 for Q3 2024.
- In Q3 2024, Non Operating Investment Income fell 546.58% year-over-year to -$42898.0; the TTM figure through Sep 2024 stood at -$21134.0 (changed N/A YoY), while the FY2023 annual figure was $71568.0, changed N/A from the prior year.
- Non Operating Investment Income for Q3 2024 stood at -$42898.0, down from -$27964.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $50434.0 in Q4 2023, with the low at -$42898.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.83 Mn | 1.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -42,898.00 |
| Sep 30, 2024 | -42,898.00 |
| Jun 30, 2024 | -27,964.00 |
| Jun 30, 2024 | -27,964.00 |
| Mar 31, 2024 | -706.00 |
| Mar 31, 2024 | -706.00 |
| Dec 31, 2023 | 50,434.00 |
| Dec 31, 2023 | 50,434.00 |
| Sep 30, 2023 | 9,606.00 |
| Sep 30, 2023 | 9,606.00 |
| Jun 30, 2023 | -26,534.00 |
| Jun 30, 2023 | -26,534.00 |
| Mar 31, 2023 | 38,062.00 |
| Mar 31, 2023 | 38,062.00 |